SCHEMBL9923910

SCHEMBL9923910

Cc1ccc2nc(N(C(=O)OC(C)(C)C)S(=O)(=O)c3ccccc3)c(Cl)n2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
KMT2A Q03164 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
MAPT P10636 2/20 0.39
POLB P06746 2/20 0.39
MEN1 O00255 1/20 0.39
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HTR6 P50406 2/20 0.37
RAB9A P51151 4/20 0.36
NPC1 O15118 3/20 0.36
HPGD P15428 2/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
HCRTR1 O43613 1/20 0.35
TP53 P04637 3/20 0.33
LMNA P02545 2/20 0.33
F2 P00734 1/20 0.33
STAT5B P51692 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9923991 0.90 ALDH1A1 (0.40) KDM4EALDH1A1KMT2ASMN1; SMN2MAPT
SCHEMBL9893254 0.87 MAPT (0.35) KDM4EALDH1A1SMN1; SMN2MAPTPOLB
SCHEMBL15631066 0.79 KMT2A (0.39) ALDH1A1KMT2ASMN1; SMN2MAPK1HTR6
SCHEMBL9893234 0.78 NR1H3 (0.34) KDM4EALDH1A1SMN1; SMN2MAPTPOLB
SCHEMBL9893443 0.73 CCR5 (0.36) KDM4EALDH1A1KMT2AHTR6HPGD
SCHEMBL15631098 0.70 TRPM8 (0.52)
SCHEMBL9893275 0.69 HSD17B10 (0.46) KDM4EALDH1A1KMT2ASMN1; SMN2MEN1
SCHEMBL9893216 0.69 PSEN1 (0.37) KDM4EALDH1A1SMN1; SMN2MAPTHTR6
SCHEMBL9923898 0.67 ALDH1A1 (0.40) KDM4EALDH1A1SMN1; SMN2MAPTPOLB
SCHEMBL9923913 0.67 KDM4E (0.43) KDM4EALDH1A1SMN1; SMN2MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9067935-B2 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2015-06-30 US disclosed
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2014-03-27 US disclosed
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPV1, TRPM2 KDM4E 3480/4885ALDH1A1 2230/4885KMT2A 1044/4885
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPV1, TRPM2 KDM4E 3480/4885ALDH1A1 2230/4885KMT2A 1044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.